Haemonetics Corporation (HAE)

Receivables turnover

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020
Revenue (ttm)	US$ in thousands	1,360,824	1,373,515	1,361,223	1,333,895	1,309,055	1,270,181	1,239,232	1,218,534	1,168,660	1,129,246	1,083,714	1,026,126	993,196	953,223	933,825	903,414	870,463	883,926	902,525	945,605
Receivables	US$ in thousands	202,657	211,949	213,534	201,485	206,562	211,611	174,249	177,117	179,142	181,100	171,532	146,463	159,376	154,980	141,305	132,908	127,555	146,939	141,533	141,094
Receivables turnover		6.71	6.48	6.37	6.62	6.34	6.00	7.11	6.88	6.52	6.24	6.32	7.01	6.23	6.15	6.61	6.80	6.82	6.02	6.38	6.70

March 31, 2025 calculation

Receivables turnover = Revenue (ttm) ÷ Receivables
= $1,360,824K ÷ $202,657K
= 6.71

The receivables turnover ratio for Haemonetics Corporation has shown some fluctuations over the period from June 30, 2020, to March 31, 2025. The ratio has ranged from a low of 6.00 to a high of 7.11 during this period. The average receivables turnover ratio over this time frame is approximately 6.53.

A higher receivables turnover ratio generally indicates that the company is collecting its accounts receivables more efficiently. In this case, we observe that the ratio has generally been above 6, suggesting that Haemonetics Corporation has been able to convert its accounts receivables into cash around 6 to 7 times per year on average.

It's important to note that a consistently high or increasing receivables turnover ratio could indicate effective credit policies and efficient collections, which is a positive sign for the company's liquidity and overall financial health. However, any significant deviations or downward trends in the ratio may warrant further investigation into the company's credit and collection practices.